-
STDY (MC $ 35M) NDA filing in 2H for MEGA Orphan Drug = Lifetime Opportunity
This Undiscovered ultra low float stock could be a Once in a Lifetime Opportunity please do your own dd and realize the MEGA Potential here .
SteadyMed (STDY) is a undiscovered stock which is close to NDA & EMA filing (expected in 4Q 2016) for their Big Orphan Drug called Trevyent? for the treatment of pulmonary arterial hypertension (PAH) . SteadyMed is trading almost at Cash Level and lots of Insider & Institutions paid over $8 per Share now trading at just $2.50 more Infos below .I think this Stock really has MEGA upside Potential .GL
SteadyMed (Nasdaq: STDY)
Market Cap: $34.9 Million
Cash: $31.8 Million
Price: $2.57
Shares Out : 13.58 Million
Insiders & Institutions holding 10.8 Million Shares
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
Forum Rules